(Corrects typo in company name in headline; Corrects source in third bullet to "Picard" from "Altitude Acquisition") April 24 (Reuters) - Picard Medical: * PICARD MEDICAL AND ITS SUBSIDIARY, SYNCARDIA SYSTEMS, A PIONEER IN TOTAL ARTIFICIAL HEART TECHNOLOGY, TO BECOME A PUBLICLY TRADED COMPANY VIA MERGER WITH ALTITUDE ACQUISITION CORP * PICARD MEDICAL: ENTERED INTO A DEFINITIVE BUSINESS COMBINATION AGREEMENT WITH ALTITUDE ACQUISITION CORP * PICARD MEDICAL- AGREEMENT WILL RESULT IN PICARD MEDICAL BECOMING A PUBLICLY LISTED COMPANY * PICARD MEDICAL: UPON CLOSING OF TRANSACTION, ALTITUDE WILL BE RENAMED PICARD MEDICAL HOLDINGS INC AND IS EXPECTED TO REMAIN LISTED ON NASDAQ * PICARD MEDICAL - PROPOSED TRANSACTION VALUES PICARD MEDICAL AT ENTERPRISE VALUE OF $480 MILLION * PICARD MEDICAL- PICARD MEDICAL STOCKHOLDERS WILL ROLL 100% OF THEIR EXISTING EQUITY HOLDINGS INTO COMBINED COMPANY * PICARD MEDICAL- SYNCARDIA IS EXPECTED TO ACHIEVE BREAK-EVEN PROFITABILITY BY 2024 Source text for Eikon: Further company coverage: ((Reutersbriefs@thomsonreuters.com;))
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.